Exit Deanxit: India bans flupentixol FDC
This article was originally published in Scrip
Executive Summary
India has prohibited the manufacture and sale of the controversial fixed-dose combination (FDC) of flupentixol and melitracen (Lundbeck's Deanxit) in the country.